Panafic Industri (538860)
Asset PlayScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1.49 |
| Market Cap | ₹12.63 Cr |
| P/E Ratio | 21.68 |
| ROCE | 0.34% |
| ROE | 2.6% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹0.6 — ₹1.49 |
| Sector | Finance |
| Book Value | ₹1.18 |
Strengths
- Price-to-book of 1.26 is modest, with book value at ₹1.18 providing some asset-level downside support.
- Piotroski F-Score of 7/9 suggests the balance sheet is not deteriorating.
- Small market cap of ₹13 crore leaves room for possible corporate or strategic interest, though this is speculative.
- The stock has moved from ₹0.60 to ₹1.49, showing market interest, but this is price momentum, not fundamental strength.
Concerns
- Return on equity is just 2.60% and ROCE is 0.34%, indicating very poor capital efficiency.
- Latest quarter shows zero sales and zero net profit; sales growth and profit growth are also zero.
- No dividend is being paid, so there is no income return while waiting for any recovery.
- Promoter holding is not available, creating poor transparency around corporate governance and alignment.
- A P/E of 21.68 looks expensive for a business with no visible growth or earnings momentum.
AI Analysis
When I look at Panafic Industri, I see a tiny non-banking financial company with a market capitalisation of just ₹13 crore. At ₹1.49, the shares trade at 1.26 times book value of ₹1.18, so there is a bit of asset support. But as Ben Graham taught, book value only matters if management can turn it into earnings. Here, return on equity is just 2.60% and return on capital employed is 0.34%. That is a very poor return on the assets entrusted to me. The latest quarter shows sales of ₹0 and net profit of ₹0, while both sales growth and profit growth are zero. The company is not generating any operating momentum, and it pays no dividend. A P/E of 21.68 on stagnant earnings is not cheap. The Piotroski F-Score of 7/9 suggests the balance sheet is not deteriorating, but a stable shell is not an operating business. The PEG ratio of 0.25 seems to promise growth, yet I see no growth in the actual numbers; this ratio is beside the point unless earnings appear. With promoter holding not available, I cannot even assess whether my interests are aligned. In many ways, this looks like an asset play: the price is close to book value, and the stock has already moved from ₹0.60 to ₹1.49, perhaps on speculative hopes. But Warren Buffett buys businesses that earn a good return on capital; Panafic does not. Without meaningful revenue, profit, dividend, or a clear turnaround, there is no margin of safety in earnings. I would leave this to speculators and stay with businesses I can understand.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer